Clinical Trial Update: Dilantin Levels With Continuous Delivery of Enteral Feedings - A Pilot Study [Phase 4]

View source ↗

Summary

A Phase 4 pilot study examined the effect of continuous enteral feeding on phenytoin (Dilantin) levels in patients with seizures; the trial was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Seizures

Drugs mentioned

• DILANTIN (Phenytoin sodium, extended release)

Snippet

Sponsor: Penn State University | Conditions: Seizures | Phase 4 | Status: TERMINATED